DexCom (DXCM) develops, manufactures, produces, and distributes continuous glucose monitoring systems for diabetes management. CEO Kevin Sayer joins Oliver Renick to discuss DXCM. He talks about DXCM's G6 system that can be used as part of an integrated system with other compatible medical devices and electronic interfaces. He talks about DXCM received FDA clearance for its next-gen G7 CGM system. Tune in to find out more about the stock market today.
05 Jan 2023
Morning Trade Live
14 Feb 2023
Market On Close
22 Feb 2023
Trading 360
10 Feb 2023
The Watch List
20 Jan 2023
Market On Close
24 Feb 2023
Trading 360
06 Jan 2023